Shenzhen Neptunus Interlong Bio-technique Co Ltd
HKEX:8329
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shenzhen Neptunus Interlong Bio-technique Co Ltd
HKEX:8329
|
CN |
|
C
|
Comcast Corp
SWB:CTP2
|
US |
|
SHL-Japan Ltd
TSE:4327
|
JP |
|
GMO Financial Holdings Inc
TSE:7177
|
JP |
|
Emmvee Photovoltaic Power Ltd
NSE:EMMVEE
|
IN |
|
P
|
Paninvest Tbk PT
XBER:OA9
|
ID |
|
E
|
ezCaretech Co Ltd
KOSDAQ:099750
|
KR |
|
S
|
Shonghoya Intl Group Inc
OTC:SNHO
|
US |
|
Y
|
Yoma Strategic Holdings Ltd
XBER:O3B
|
SG |
|
Nankai Plywood Co Ltd
TSE:7887
|
JP |
|
Severstal' PAO
OTC:SVJTY
|
RU |
|
D
|
DevEx Resources Ltd
OTC:UREQF
|
AU |
|
C
|
China Starch Holdings Ltd
OTC:CHNSF
|
HK |
|
Bed Bath & Beyond Inc
NYSE:BBBY
|
US |
Shenzhen Neptunus Interlong Bio-technique Co Ltd
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. engages in the research and development, production and sales of medicines, the purchase and sales of medicines and healthcare food products. The company is headquartered in Shenzhen, Guangdong and currently employs 1,401 full-time employees. The company went IPO on 2005-09-12. The firm operates through three segments. Medicines segment is engaged in the manufacture and sales of medicines. Medicines and Healthcare Products segment is engaged in the sales and distribution of medicines and healthcare products. Research and Development Services of Modern Biological Technology segment is engaged in the provision of research and development services of modern biological technologies, such as in vitro diagnostics reagents businesses. The products of the Company include herbal medicines, generic drugs, transfusion and anti-tumor drugs, among others. The firm mainly operates businesses in China.
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. engages in the research and development, production and sales of medicines, the purchase and sales of medicines and healthcare food products. The company is headquartered in Shenzhen, Guangdong and currently employs 1,401 full-time employees. The company went IPO on 2005-09-12. The firm operates through three segments. Medicines segment is engaged in the manufacture and sales of medicines. Medicines and Healthcare Products segment is engaged in the sales and distribution of medicines and healthcare products. Research and Development Services of Modern Biological Technology segment is engaged in the provision of research and development services of modern biological technologies, such as in vitro diagnostics reagents businesses. The products of the Company include herbal medicines, generic drugs, transfusion and anti-tumor drugs, among others. The firm mainly operates businesses in China.
